Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Puberty | 9 | 2024 | 58 | 4.080 |
Why?
|
| Barrett Esophagus | 13 | 2013 | 114 | 2.410 |
Why?
|
| Esophageal Neoplasms | 14 | 2013 | 115 | 2.100 |
Why?
|
| Obesity | 11 | 2022 | 814 | 1.700 |
Why?
|
| Mindfulness | 3 | 2025 | 30 | 1.650 |
Why?
|
| Adenocarcinoma | 12 | 2013 | 173 | 1.630 |
Why?
|
| Body Mass Index | 14 | 2022 | 937 | 1.440 |
Why?
|
| Puberty, Precocious | 2 | 2022 | 8 | 1.420 |
Why?
|
| Gastroesophageal Reflux | 11 | 2014 | 77 | 1.420 |
Why?
|
| Pediatric Obesity | 2 | 2022 | 88 | 1.390 |
Why?
|
| Stomach Neoplasms | 6 | 2008 | 42 | 1.180 |
Why?
|
| Female | 41 | 2025 | 12396 | 1.180 |
Why?
|
| Diabetes, Gestational | 4 | 2017 | 311 | 1.170 |
Why?
|
| Humans | 48 | 2025 | 17314 | 1.100 |
Why?
|
| Diet | 5 | 2013 | 355 | 1.090 |
Why?
|
| Cardia | 6 | 2008 | 15 | 1.040 |
Why?
|
| Depression, Postpartum | 1 | 2025 | 22 | 0.930 |
Why?
|
| Child | 10 | 2024 | 2403 | 0.910 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2014 | 22 | 0.880 |
Why?
|
| Hepatitis B Vaccines | 2 | 2014 | 44 | 0.870 |
Why?
|
| Hepatitis B | 2 | 2014 | 45 | 0.860 |
Why?
|
| Menarche | 2 | 2022 | 28 | 0.860 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2016 | 168 | 0.810 |
Why?
|
| Pregnancy | 9 | 2025 | 1463 | 0.780 |
Why?
|
| Male | 30 | 2024 | 9804 | 0.760 |
Why?
|
| Adolescent | 15 | 2024 | 3538 | 0.730 |
Why?
|
| California | 14 | 2025 | 2311 | 0.710 |
Why?
|
| Risk Factors | 18 | 2019 | 3258 | 0.710 |
Why?
|
| Adult | 26 | 2025 | 7500 | 0.690 |
Why?
|
| Caregivers | 2 | 2019 | 128 | 0.680 |
Why?
|
| Stress, Psychological | 3 | 2019 | 134 | 0.650 |
Why?
|
| Breast Feeding | 1 | 2019 | 113 | 0.570 |
Why?
|
| Case-Control Studies | 13 | 2014 | 1098 | 0.560 |
Why?
|
| Antioxidants | 2 | 2008 | 40 | 0.560 |
Why?
|
| Middle Aged | 23 | 2019 | 7836 | 0.550 |
Why?
|
| Dietary Fiber | 3 | 2013 | 60 | 0.480 |
Why?
|
| Precancerous Conditions | 5 | 2013 | 48 | 0.480 |
Why?
|
| Weight Gain | 1 | 2017 | 156 | 0.480 |
Why?
|
| Young Adult | 11 | 2025 | 2465 | 0.450 |
Why?
|
| Heartburn | 1 | 2014 | 4 | 0.450 |
Why?
|
| Child, Preschool | 3 | 2024 | 1380 | 0.430 |
Why?
|
| Neoplasms | 1 | 2019 | 446 | 0.420 |
Why?
|
| Adiposity | 1 | 2014 | 67 | 0.420 |
Why?
|
| Quality of Life | 3 | 2019 | 499 | 0.410 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2008 | 56 | 0.410 |
Why?
|
| Feeding Behavior | 1 | 2014 | 163 | 0.410 |
Why?
|
| Infant, Newborn | 3 | 2022 | 805 | 0.410 |
Why?
|
| Surveys and Questionnaires | 7 | 2019 | 1282 | 0.410 |
Why?
|
| Prospective Studies | 3 | 2022 | 1226 | 0.400 |
Why?
|
| Waist Circumference | 1 | 2013 | 33 | 0.400 |
Why?
|
| Alcohol Drinking | 3 | 2014 | 356 | 0.380 |
Why?
|
| Patient Compliance | 1 | 2014 | 277 | 0.380 |
Why?
|
| Fruit | 2 | 2010 | 80 | 0.370 |
Why?
|
| Vegetables | 2 | 2010 | 88 | 0.370 |
Why?
|
| Life Style | 3 | 2016 | 316 | 0.350 |
Why?
|
| Aged | 17 | 2018 | 6084 | 0.350 |
Why?
|
| Yoga | 1 | 2011 | 25 | 0.340 |
Why?
|
| Cohort Studies | 4 | 2022 | 2514 | 0.340 |
Why?
|
| Smoking | 2 | 2014 | 429 | 0.340 |
Why?
|
| Micronutrients | 1 | 2010 | 9 | 0.340 |
Why?
|
| Telemedicine | 2 | 2025 | 181 | 0.310 |
Why?
|
| Meat | 1 | 2009 | 27 | 0.300 |
Why?
|
| Beer | 1 | 2008 | 9 | 0.300 |
Why?
|
| Wine | 1 | 2008 | 18 | 0.300 |
Why?
|
| Dietary Fats | 1 | 2009 | 89 | 0.290 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 674 | 0.270 |
Why?
|
| Age Factors | 4 | 2019 | 878 | 0.270 |
Why?
|
| Cross-Sectional Studies | 5 | 2025 | 1280 | 0.270 |
Why?
|
| Feasibility Studies | 3 | 2019 | 108 | 0.270 |
Why?
|
| Continental Population Groups | 3 | 2019 | 286 | 0.260 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2025 | 535 | 0.250 |
Why?
|
| Transients and Migrants | 1 | 2005 | 3 | 0.240 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2025 | 5 | 0.240 |
Why?
|
| Mexican Americans | 1 | 2005 | 42 | 0.240 |
Why?
|
| Heart Failure | 1 | 2011 | 401 | 0.230 |
Why?
|
| Risk-Taking | 1 | 2005 | 106 | 0.230 |
Why?
|
| Incidence | 7 | 2010 | 1266 | 0.220 |
Why?
|
| Sexual Maturation | 1 | 2024 | 8 | 0.220 |
Why?
|
| Hawaii | 1 | 2024 | 58 | 0.220 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 312 | 0.220 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 701 | 0.210 |
Why?
|
| Coffee | 1 | 2003 | 5 | 0.200 |
Why?
|
| Pregnancy Complications | 1 | 2025 | 197 | 0.200 |
Why?
|
| Treatment Outcome | 2 | 2019 | 1160 | 0.190 |
Why?
|
| Overweight | 2 | 2014 | 266 | 0.180 |
Why?
|
| Logistic Models | 4 | 2008 | 879 | 0.180 |
Why?
|
| Depression | 1 | 2025 | 486 | 0.170 |
Why?
|
| Sex Factors | 4 | 2013 | 603 | 0.160 |
Why?
|
| Retrospective Studies | 2 | 2024 | 2415 | 0.160 |
Why?
|
| SEER Program | 3 | 2004 | 92 | 0.160 |
Why?
|
| Mental Health | 1 | 2021 | 169 | 0.160 |
Why?
|
| Hispanic Americans | 4 | 2021 | 375 | 0.150 |
Why?
|
| HIV Infections | 1 | 2005 | 712 | 0.150 |
Why?
|
| Meditation | 1 | 2019 | 17 | 0.150 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 78 | 0.150 |
Why?
|
| Helicobacter Infections | 2 | 2008 | 22 | 0.140 |
Why?
|
| Helicobacter pylori | 2 | 2008 | 24 | 0.140 |
Why?
|
| Pilot Projects | 2 | 2011 | 211 | 0.140 |
Why?
|
| European Continental Ancestry Group | 5 | 2021 | 476 | 0.140 |
Why?
|
| United States | 5 | 2016 | 3866 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 437 | 0.130 |
Why?
|
| Social Support | 1 | 2018 | 207 | 0.130 |
Why?
|
| Medication Adherence | 1 | 2018 | 235 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 390 | 0.120 |
Why?
|
| Citrus | 1 | 2014 | 3 | 0.110 |
Why?
|
| Lycopersicon esculentum | 1 | 2014 | 4 | 0.110 |
Why?
|
| Tea | 1 | 2014 | 8 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 5 | 0.110 |
Why?
|
| Diet, Fat-Restricted | 1 | 2014 | 36 | 0.110 |
Why?
|
| Carbonated Beverages | 1 | 2014 | 15 | 0.110 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2014 | 15 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2014 | 65 | 0.110 |
Why?
|
| Perinatal Care | 1 | 2014 | 12 | 0.110 |
Why?
|
| Hepatitis B virus | 1 | 2014 | 25 | 0.110 |
Why?
|
| Viral Load | 1 | 2014 | 136 | 0.100 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 13 | 0.100 |
Why?
|
| Risk | 1 | 2014 | 496 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2008 | 640 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2014 | 314 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 622 | 0.090 |
Why?
|
| Esophagoscopy | 2 | 2009 | 19 | 0.090 |
Why?
|
| Socioeconomic Factors | 2 | 2018 | 605 | 0.090 |
Why?
|
| Iron | 2 | 2008 | 16 | 0.090 |
Why?
|
| Confounding Factors (Epidemiology) | 2 | 2008 | 84 | 0.090 |
Why?
|
| Confidence Intervals | 2 | 2008 | 231 | 0.090 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 11 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 357 | 0.090 |
Why?
|
| Ethnic Groups | 2 | 2011 | 451 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 969 | 0.080 |
Why?
|
| Histamine H2 Antagonists | 1 | 2010 | 13 | 0.080 |
Why?
|
| Proton Pump Inhibitors | 1 | 2010 | 24 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 664 | 0.080 |
Why?
|
| Hip Fractures | 1 | 2010 | 71 | 0.080 |
Why?
|
| Disease Progression | 1 | 2010 | 259 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 1925 | 0.080 |
Why?
|
| Trans Fatty Acids | 1 | 2009 | 4 | 0.080 |
Why?
|
| Cooking | 1 | 2009 | 17 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2009 | 21 | 0.080 |
Why?
|
| Ferritins | 1 | 2008 | 8 | 0.070 |
Why?
|
| Geography | 1 | 2008 | 39 | 0.070 |
Why?
|
| Ascorbic Acid | 1 | 2008 | 18 | 0.070 |
Why?
|
| beta Carotene | 1 | 2008 | 17 | 0.070 |
Why?
|
| Vitamin E | 1 | 2008 | 20 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2007 | 1076 | 0.070 |
Why?
|
| Hemochromatosis | 1 | 2008 | 7 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2008 | 7 | 0.070 |
Why?
|
| Animals | 1 | 2009 | 280 | 0.070 |
Why?
|
| Principal Component Analysis | 1 | 2008 | 24 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2008 | 38 | 0.070 |
Why?
|
| Interviews as Topic | 1 | 2008 | 306 | 0.070 |
Why?
|
| Mutation | 1 | 2008 | 132 | 0.070 |
Why?
|
| Abdominal Fat | 1 | 2007 | 13 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2008 | 304 | 0.070 |
Why?
|
| Central America | 1 | 2005 | 4 | 0.060 |
Why?
|
| Mexico | 1 | 2005 | 18 | 0.060 |
Why?
|
| Condoms | 1 | 2005 | 33 | 0.060 |
Why?
|
| Intracranial Hemorrhages | 1 | 2005 | 16 | 0.060 |
Why?
|
| Health Surveys | 1 | 2005 | 245 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2005 | 128 | 0.060 |
Why?
|
| Asian Americans | 1 | 2005 | 163 | 0.050 |
Why?
|
| Prenatal Care | 1 | 2025 | 127 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 298 | 0.050 |
Why?
|
| Personality | 1 | 2003 | 9 | 0.050 |
Why?
|
| Health Behavior | 1 | 2005 | 346 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2005 | 367 | 0.050 |
Why?
|
| Stroke | 1 | 2005 | 309 | 0.050 |
Why?
|
| Asian Continental Ancestry Group | 2 | 2016 | 87 | 0.050 |
Why?
|
| Alcoholism | 1 | 2005 | 337 | 0.050 |
Why?
|
| African Continental Ancestry Group | 2 | 2016 | 144 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 535 | 0.050 |
Why?
|
| Health Status | 1 | 2003 | 293 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2005 | 425 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2020 | 5 | 0.040 |
Why?
|
| New York | 1 | 2020 | 17 | 0.040 |
Why?
|
| Child Abuse | 1 | 2020 | 43 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 50 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 43 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 75 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 53 | 0.040 |
Why?
|
| Bias | 2 | 2008 | 96 | 0.040 |
Why?
|
| Focus Groups | 1 | 2018 | 143 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 114 | 0.040 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 65 | 0.030 |
Why?
|
| Abdomen | 2 | 2008 | 20 | 0.030 |
Why?
|
| Disease Management | 1 | 2018 | 111 | 0.030 |
Why?
|
| Parents | 1 | 2020 | 297 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 145 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 560 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 206 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 302 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 1151 | 0.030 |
Why?
|
| Exercise | 1 | 2016 | 515 | 0.020 |
Why?
|
| Gastric Acid | 1 | 2010 | 4 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 120 | 0.020 |
Why?
|
| Systematized Nomenclature of Medicine | 1 | 2009 | 5 | 0.020 |
Why?
|
| Metaplasia | 1 | 2009 | 7 | 0.020 |
Why?
|
| Observer Variation | 1 | 2009 | 36 | 0.020 |
Why?
|
| Esophagus | 1 | 2009 | 12 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 32 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 30 | 0.020 |
Why?
|
| Iron, Dietary | 1 | 2008 | 8 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 82 | 0.020 |
Why?
|
| Hemochromatosis Protein | 1 | 2008 | 7 | 0.020 |
Why?
|
| Homozygote | 1 | 2008 | 13 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2009 | 86 | 0.020 |
Why?
|
| Heterozygote | 1 | 2008 | 26 | 0.020 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2008 | 8 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2007 | 8 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 13 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 33 | 0.020 |
Why?
|
| Thigh | 1 | 2007 | 11 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2007 | 23 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2007 | 31 | 0.020 |
Why?
|
| Anthropometry | 1 | 2006 | 60 | 0.020 |
Why?
|
| Prevalence | 1 | 2008 | 840 | 0.020 |
Why?
|
| Age Distribution | 1 | 2006 | 239 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 372 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 1039 | 0.010 |
Why?
|
| African Americans | 1 | 2005 | 439 | 0.010 |
Why?
|
Concepts
(219)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->